Literature DB >> 3494190

Residual nitrobenzylthioinosine-resistant nucleoside transport in a transport mutant (AE1) of S49 murine T-lymphoma cells.

P G Plagemann, C Woffendin.   

Abstract

The uptake of various nucleosides by S49 mouse T-lymphoma cells and that by a single-step nucleoside transport-defective mutant thereof (AE1) were compared. Residual nucleoside entry into AE1 cells occurred via two routes, nonmediated permeation and saturable, non-concentrative transport with broad substrate specificity and a Michaelis-Menten constant approximating that for thymidine transport in wild-type cells. However, in contrast to nucleoside transport in wild-type cells, residual nucleoside transport in AE1 cells was resistant to inhibition by nitrobenzylthioinosine. In its properties the latter resembled nitrobenzylthioinosine-resistant nucleoside transport observed in other types of mammalian cells. It amounted to less than 1% of the total nucleoside transport activity of wild-type S49 cells. The results indicate that nitrobenzylthioinosine-resistant and -sensitive nucleoside transports are genetically distinguishable. In wild-type cells, the salvage of thymidine, when present at concentrations higher than 1 to 10 microM, was limited by phosphorylation, because of the saturation of thymidine kinase. In AE1 cells, entry into the cells mainly limited thymidine salvage, but at high thymidine concentrations the combined entry via residual transport and nonmediated permeation was sufficiently rapid to support intracellular thymidine phosphorylation at rates comparable to those observed in wild-type cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494190      PMCID: PMC365052          DOI: 10.1128/mcb.7.1.160-166.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  Sodium gradient-energized concentrative transport of adenosine in renal brush border vesicles.

Authors:  M Le Hir; U C Dubach
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

2.  Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cells.

Authors:  P G Plagemann; R M Wohlhueter
Journal:  Biochim Biophys Acta       Date:  1985-06-27

3.  Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine.

Authors:  P G Plagemann; R M Wohlhueter
Journal:  Biochim Biophys Acta       Date:  1984-06-13

4.  Kinetic and thermodynamic studies on nitrobenzylthioinosine binding to the nucleoside transporter of Chinese hamster ovary cells.

Authors:  R M Wohlhueter; W E Brown; P G Plagemann
Journal:  Biochim Biophys Acta       Date:  1983-06-10

5.  Genetic analysis of the 6-thiobenzylpurine binding site of the nucleoside transporter in mouse lymphoblasts.

Authors:  B Aronow; B Ullman
Journal:  Proc Soc Exp Biol Med       Date:  1985-09

6.  Characterization of mouse lymphoma cells with altered nucleoside transport.

Authors:  A Cohen; C Leung; E Thompson
Journal:  J Cell Physiol       Date:  1985-06       Impact factor: 6.384

7.  Altered nucleoside transporters in mammalian cells selected for resistance to the physiological effects of inhibitors of nucleoside transport.

Authors:  B Aronow; K Allen; J Patrick; B Ullman
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

8.  Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.

Authors:  J A Belt
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

9.  Adenosine metabolism in wild-type and enzyme-deficient variants of Chinese hamster ovary and Novikoff rat hepatoma cells.

Authors:  P G Plagemann; R M Wohlhueter
Journal:  J Cell Physiol       Date:  1983-08       Impact factor: 6.384

10.  Uridine uptake by isolated intestinal epithelial cells of guinea pig.

Authors:  M Schwenk; E Hegazy; V Lopez del Pino
Journal:  Biochim Biophys Acta       Date:  1984-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.